iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionExencial Wealth Advisors, Llc
Latest Disclosed Ownership2,219 shares
Latest Disclosed Value $ 374,648
Exencial Wealth Advisors, Llc reports 2.76% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 27, 2026 - Exencial Wealth Advisors, Llc filed a 13F-HR form disclosing ownership of 2,219 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $374,648 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 2,282 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -2.76% during the quarter. The current value of the position is $290,800 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,219 -63 -2.76 375 -2.86 0.0107
2026-01-30 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,282 0 0.00 385 17.02 0.0122
2025-10-27 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,282 0 0.00 329 14.24 0.0107
2025-07-30 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,282 -297 -11.52 289 -12.46 0.0102
2025-05-09 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,579 -108 -4.02 330 -7.32 0.0122
2025-02-06 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,687 1 0.04 355 -9.21 0.0130
2024-10-31 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,686 -299 -10.02 391 -4.40 0.0140
2024-08-12 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,985 -307 -9.33 410 -9.31 0.0154
2024-05-10 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,292 -174 -5.02 452 -4.04 0.0169
2024-02-13 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,466 1 0.03 471 11.11 0.0192
2023-11-08 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,465 -22 -0.63 424 -4.30 0.0205
2023-08-10 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,487 86 2.53 443 0.68 0.0203
2023-05-02 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,401 -71 -2.04 439 -3.52 0.0227
2023-02-14 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,472 121 3.61 456 16.07 0.0245
2022-11-08 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,351 -2,084 -38.34 392 -38.65 0.0237
2022-08-11 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,435 -2,586 -32.24 639 -38.85 0.0361
2022-05-12 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 8,021 -6,007 -42.82 1,045 -51.19 0.0525
2022-02-10 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 14,028 14,028 2,141 0.1036
2021-11-04 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 0 -1,602 -100.00 0 -100.00
2021-08-16 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,602 -58 -3.49 262 4.80 0.0142
2021-05-06 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,660 0 0.00 250 -0.40 0.0148
2021-02-11 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,660 -1,530 -47.96 251 -41.90 0.0171
2020-11-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,190 0 0.00 432 -0.92 0.0229
2020-08-17 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,190 3,190 436 0.0378
2020-05-15 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -2,755 -100.00 0 -100.00
2020-02-14 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,755 -450 -14.04 332 4.08 0.0575
2019-11-13 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,205 -88 -2.67 319 -11.14 0.0686
2019-08-14 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,293 -300 -8.35 359 -10.70 0.0838
2019-05-08 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,593 -385 -9.68 402 4.69 0.0954
2019-02-06 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,978 711 21.76 384 -3.52 0.1031
2018-11-02 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,267 351 12.04 398 24.38 0.0926
2018-07-31 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,916 90 3.18 320 5.96 0.0891
2018-05-08 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,826 -153 -5.14 302 -5.03 0.0898
2018-02-09 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,979 1,745 141.41 318 -22.82 0.0958
2017-11-08 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 1,234 10 0.82 412 8.42 0.1357
2017-08-10 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,224 105 9.38 380 17.65 0.1556
2017-04-26 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,119 187 20.06 323 30.77 0.1401
2017-01-20 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 932 932 247 0.1046
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.